ExodusPoint Capital Management’s MediciNova MNOV Stock Holding History

ExodusPoint Capital Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,157	Closed	-$31K	–	2106
2023 Q1	$31K	Sell	14,157 -9,027	-39%	-$20.7K	﹤0.01%	1680
2022 Q4	$48K	Buy	+23,184	New	+$51.2K	﹤0.01%	1548
2021 Q3	–	Sell	-15,224	Closed	-$65K	–	2438
2021 Q2	$65K	Buy	+15,224	New	+$65.6K	﹤0.01%	2198

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ExodusPoint Capital Management's MNOV Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of MediciNova (MNOV) in Q2 2023, closing a stake of 14,157 shares — an estimated $31K sold.

ExodusPoint Capital Management first reported a position in MNOV in Q2 2021 and held it in 3 quarters. The position peaked at $65K in Q2 2021. 34 funds tracked by Wall St. Rank hold MNOV as of Q2 2023.

ExodusPoint Capital Management reported no remaining MediciNova position as of Q2 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 14,157 MediciNova shares in Q2 2023, an estimated $31K.
ExodusPoint Capital Management first reported a position in MediciNova in Q2 2021 and held it in 3 quarters.
ExodusPoint Capital Management's MediciNova position peaked at $65K in Q2 2021.
34 funds tracked by Wall St. Rank held MediciNova as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.